geraniol has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Liu, G; Yang, H; Yang, Z; Zhao, H | 1 |
Crespo, R; de Bravo, MG; Galle, M; Kladniew, BR; Polo, M; Villegas, SM | 1 |
2 other study(ies) available for geraniol and Adenocarcinoma
Article | Year |
---|---|
Inhibiting the JNK/ERK signaling pathway with geraniol for attenuating the proliferation of human gastric adenocarcinoma AGS cells.
Topics: Acyclic Monoterpenes; Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Neoplasm Proteins; Stomach Neoplasms | 2021 |
Suppression by geraniol of the growth of A549 human lung adenocarcinoma cells and inhibition of the mevalonate pathway in culture and in vivo: potential use in cancer chemotherapy.
Topics: Acyclic Monoterpenes; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cholesterol; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Lung Neoplasms; Mevalonic Acid; Mice; Mice, Nude; Terpenes; Xenograft Model Antitumor Assays | 2014 |